Bradley P. Dixon, MD, FASN / Carla M. Nester, MD, MSA, FASN - Getting to the Root of the Problem: Unlocking the Potential of Novel Complement Inhibitors in C3G and IC-MPGN

Visit https://www.peervoice.com/XBG860 to view the entire programme with slides. After completing “Bradley P. Dixon, MD, FASN / Carla M. Nester, MD, MSA, FASN - Getting to the Root of the Problem: Unlocking the Potential of Novel Complement Inhibitors in C3G and IC-MPGN”, participants will be able to: Describe the limitations of current therapeutic approaches to immunosuppression in patients with C3G and IC-MPGN; Utilize evidence-based treatment strategies to optimize outcomes for patients with C3G and IC-MPGN; Evaluate the mechanistic rationale of therapies targeting different components of the classical and alternative complement pathway in C3G and IC-MPGN; and Discuss recent data from clinical trials examining the safety and efficacy of emerging complement inhibitors in patients with C3G and IC-MPGN.